Sanofi Consumer Healthcare India Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi Consumer Healthcare India has filed its financial results with the Exchange for the period ending September 30, 2025, covering the second quarter and first half of FY26. The announcement itself does not include the actual numbers — only the fact of submission. Investors should look at the accompanying results PDF for revenue, profit, and margin details. Sanofi Consumer Healthcare India (formerly known as Sanofi India) is the listed consumer health entity that emerged from the demerger of Sanofi's healthcare business from its vaccines operations (the vaccines business now listed as Sanofi Biotech India).
This is a routine stock-exchange filing confirming that the company has met its disclosure obligations. It is not material by itself; the actual financial performance will be in the detailed results document, which is where investors should focus.